First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trial

Additional Metadata
Keywords	clinical trials (CLIN), coronary artery disease (CAD), percutaneous coronary intervention (PCI), percutaneous coronary intervention complex (PCIC)
Persistent URL	doi.org/10.1002/ccd.26344, hdl.handle.net/1765/96062
Journal	Catheterization and Cardiovascular Interventions
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Grundeken, M., Wykrzykowska, J., Ishibashi, Y., Garg, S., de Vries, T., Garcia-Garcia, H., Onuma, Y., de Winter, R., Buszman, P., Linke, A., Ischinger, T., Klauss, V., Eberli, F. R., Corti, R., Wijns, W., Morice, M.-C., di Mario, C., Meier, B. (Bernhard), Jüni, P., … Serruys, P. (2016). First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trial. Catheterization and Cardiovascular Interventions, 87(7), 248–260.https://doi.org/10.1002/ccd.26344

Publication